President Joe Biden ended his reelection bid at 1:46pm on July 21, posting a letter on social media from his vacation home in Delaware. At 2:13pm, he endorsed Vice President Kamala Harris as his successor. In those 27 minutes, Harris spoke to nearly a dozen key Democrats, persuading them to back her, and all of them did. At 4:48pm, she filed the first application with the Federal Election Commission about the change atop the Democratic ticket, marking the formal transition of the campaign.
Harris was ready. She was at her Naval Observatory residence in Washington, DC, when Biden told her about his decision to quit. She immediately summoned her team, which had an inkling that something momentous was happening. By the time they called it a day, Harris had contacted more than 100 Democratic stalwarts, including Bill and Hillary Clinton, Barack Obama, Nancy Pelosi, Congressional leaders and, most importantly, her potential rivals for nomination—Governors Gretchen Whitmer, J.B. Pritzker and Josh Shapiro. Her team simultaneously worked the phones to convince convention delegates, numbering around 4,000, who have the mandate to choose the nominee.
In less than two days, Harris won over 3,100 delegates, secured endorsements from prominent Democrats, cleared the field of every serious contender and raised nearly $125 million (approximately ₹1,050 crore). By quickly sealing the nomination, she killed the demand for an open convention, which was said to be preferred by at least a few in the party, including Obama. (Michelle and Barack Obama endorsed her three days later.) Harris has all but clinched the Democratic nomination; technically, she has to wait till the Democratic Party completes its formal roll call of delegates to finalise its candidate, which could happen latest by August 7.
Esta historia es de la edición August 11, 2024 de THE WEEK India.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición August 11, 2024 de THE WEEK India.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
Hat-Trick Or Has-Beens?
India look to win their third straight Test series in Australia, but ageing superstars and recent humiliation at home have cast a shadow on their hopes
Constipation Can Put Your Heart At Risk
PEOPLE WITH CONSTIPATION have an increased risk of major cardiac events, including heart attack, stroke and heart failure, especially if they also have high blood pressure, finds an international study published in the American Journal of Physiology-Heart and Circulatory Physiology.
Too Much Sitting Can Accelerate Ageing
SITTING FOR EXTENDED PERIODS can harm the heart and accelerate ageing, even if you are young and get the minimum recommended amount of daily exercise, according to a US study published in the journal PLOS One.
Efficiency and innovation
As health care evolves, professionals must employ innovative methods to refine their skills
Level up
Only 30 per cent of needy patients are able to undergo transplant in India; we need more dedicated transplant centres
HOPE STEMS FROM A CELL
While stem cell therapies have shown success in treating blood disorders, orthopaedic ailments, autoimmune diseases and eye issues, there is hope that they can one day treat patients with heart disease, blindness, Parkinson's, HIV, diabetes and spinal cord injuries
Mind matters
Your mindset can limit or expand your physical ability
Cutting edge
Would you go under the knife if a robot was the one holding it? Or would you say, \"No way, I need a human touch\"? You might have to decide soon because a robot that can imitate skilled human surgeons is already here.
The smallest cut
Minimally invasive surgeries have a bright future, with virtual reality and 3D procedures offering greater precision and AI on the horizon
Signalling a revolution
Canadian scientist and entrepreneur Sachdev Sidhu is focused on bringing cutting-edge antibody engineering to his country of origin